Market capitalization | GBP781.88m |
Enterprise Value | GBP1.03b |
EV/FCF (TTM) EV/FCF | 5.79 |
EV/Sales (TTM) EV/Sales | 1.30 |
P/S ratio (TTM) P/S ratio | 0.99 |
P/B ratio (TTM) P/B ratio | 2.09 |
Dividend yield | 2.32% |
Last dividend (FY25) | GBP0.02 |
Revenue growth (TTM) Revenue growth | -10.20% |
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
7 Analysts have issued a Dr Martens forecast:
7 Analysts have issued a Dr Martens forecast:
Mar '25 |
+/-
%
|
||
Revenue | 788 788 |
10%
10%
|
|
Gross Profit | 512 512 |
11%
11%
|
|
EBITDA | 142 142 |
28%
28%
|
EBIT (Operating Income) EBIT | 70 70 |
45%
45%
|
Net Profit | 4.50 4.50 |
93%
93%
|
In millions GBP.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
Head office | United Kingdom |
CEO | Ije Nwokorie |
Employees | 2,630 |
Founded | 1945 |
Website | www.drmartensplc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.